Article

PDA Initiates Quality Culture Survey

PDA surveys are designed to evaluate quality metrics practices at member organizations.

The Parenteral Drug Association (PDA) launched on Sept. 5 the first of two surveys on quality culture metrics as part the organization’s continuing program to evaluate quality metrics that can inform the regulator’s risk-based inspection programs.

A link to first survey has been sent to selected PDA members with a background or interest in pharmaceutical quality. On Sept. 6, a second survey was launched with controlled participation limited to three or four executives at selected companies. The surveys will be open for participation until Oct. 2, 2014.

PDA reports that it is conducting the 2014 PDA Quality Culture Metrics Survey to understand to what degree PDA members’ companies are measuring quality culture and to identify attributes of quality culture appropriate for use as metrics. Respondents are encouraged to base their answers on tools and approaches used at their local work site or facility, the organization reports.

Results will be presented at the 2014 PDA Pharmaceutical Quality Metrics Conference on Dec. 4, 2014 in Washington, DC.

Source: Partenteral Drug Association

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More
Related Content